“The only comparable therapy that brings up the on time to the extent or the magnitude that this gel does is deep-brain stimulation, so the future of studies will require direct head-to-head comparisons between deep-brain stimulation and levodopa-carbidopa gel,” Espay told Medscape Medical News. “It cannot be compared with any of the oral medications for Parkinson’s disease.”